Proterguride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProterguride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonistsSerotonin (5-HT) receptor antagonists
TargetsDopamine receptorsSerotonin (5-HT) receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSpofaBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpofaBayer AG
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A